Christophe Meille

3PUBLICATIONS
8CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 04, 2021
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia.

Eytan M Stein, Daniel J DeAngelo, Jörg Chromik

Pageof 1